Osteogenic Sarcoma

Clinical Features

Phenotypes and symptoms related to Osteogenic Sarcoma

  • Short stature
  • Neoplasm
  • Abnormality of metabolism/homeostasis
  • Sarcoma
  • Osteosarcoma
  • Retinoblastoma
  • Chondrosarcoma
  • Embryonal neoplasm

Incidence and onset information

— Based on the latest data available OSTEOGENIC SARCOMA have a estimated incidence of 0.8 per 100k worldwide.
No data available about the known clinical features onset.

Alternative names

Osteogenic Sarcoma Is also known as osteosarcoma, osrc.

Researches and researchers

Doctors, researchs, and experts related to Osteogenic Sarcoma extracted from public data.

Osteogenic Sarcoma Experts map



Current Researchs and researchers

  • WIEN — Pr Ruth LADENSTEIN

    Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project - Coordinator of expert centre network - Coordinator of research network

    • Institution/s:
      — St. Anna Kinderkrebsforschung
      — St. Anna Kinderspital
    • Research area/topic::

      ENCCA: EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS


  • LYON — Pr Jean-Yves BLAY

    Coordinator of expert centre - Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project - Coordinator of expert centre network - Coordinator of research network

    • Institution/s:
      — Pavillon P et Oncologie médicale du centre Léon Bérard, CHU de Lyon HCL - GH Edouard Herriot
      — CLCC Léon Bérard
      — CLCC Léon Bérard
    • Research area/topic::

      French Sarcoma study group: study group of bone tumors


  • VILLEJUIF — Pr Gilles VASSAL

    Clinical expert - Principal investigator of clinical trial - Investigator of research project

    • Institution/s:
      — CLCC Institut Gustave Roussy
      — CLCC Institut Gustave Roussy
    • Research area/topic::

      ENCCA: EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS - FR


  • BIELEFELD — Pr Jörg T. HARTMANN

    Principal investigator of clinical trial - Investigator of research project

    • Institution/s:
      — Franziskus Hospital Bielefeld
    • Research area/topic::

      SAREZ : Sarcoma Relapse Registry for relapsed sarcoma of bone and soft tissues


  • ESSEN — Pr Uta DIRKSEN

    Principal investigator of clinical trial - Investigator of research project - Coordinator of research network

    • Institution/s:
      — Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Essen
    • Research area/topic::

      TranSarNet: translational sarcoma research network


Osteogenic Sarcoma Recommended genes panels

Panel Name, Specifity and genes Tested/covered
TP53 Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

TP53
Specificity
100 %
Genes
50 %
TP53 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

TP53
Specificity
100 %
Genes
50 %
TP53 Sequence Analysis.

By Baylor Miraca Genetics Laboratories (United States).

TP53
Specificity
100 %
Genes
50 %
TP53 Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories (United States).

TP53
Specificity
100 %
Genes
50 %
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
100 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
50 %
Hereditary High Risk Breast Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
50 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
50 %

You can get up to 457 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM ORPHANET Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1 SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA RH-NULL, REGULATOR TYPE; RHN NEVOID HYPERMELANOSIS, LINEAR AND WHORLED; LWNH AMELOGENESIS IMPERFECTA-GINGIVAL HYPERPLASIA SYNDROME FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3 HOLOPROSENCEPHALY 7; HPE7